Signal Advisors Wealth LLC Has $601,000 Position in The Cigna Group (NYSE:CI)

Signal Advisors Wealth LLC grew its position in The Cigna Group (NYSE:CI - Free Report) by 106.2% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,827 shares of the health services provider's stock after purchasing an additional 941 shares during the period. Signal Advisors Wealth LLC's holdings in The Cigna Group were worth $601,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the company. TCTC Holdings LLC bought a new stake in The Cigna Group during the fourth quarter worth about $25,000. Collier Financial bought a new stake in shares of The Cigna Group during the 4th quarter worth approximately $32,000. Putney Financial Group LLC acquired a new stake in shares of The Cigna Group in the 4th quarter valued at approximately $36,000. Compagnie Lombard Odier SCmA bought a new position in shares of The Cigna Group in the fourth quarter valued at $37,000. Finally, Transce3nd LLC acquired a new position in The Cigna Group during the fourth quarter worth $38,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other The Cigna Group news, Director Elder Granger sold 2,376 shares of the business's stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $310.35, for a total transaction of $737,391.60. Following the completion of the transaction, the director now owns 5,471 shares of the company's stock, valued at approximately $1,697,924.85. The trade was a 30.28% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.70% of the company's stock.

The Cigna Group Stock Performance

Shares of CI traded up $1.33 during mid-day trading on Monday, hitting $313.51. 1,447,385 shares of the company's stock were exchanged, compared to its average volume of 1,695,365. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83. The stock's 50-day simple moving average is $323.39 and its 200-day simple moving average is $308.90. The firm has a market cap of $83.75 billion, a price-to-earnings ratio of 25.60, a price-to-earnings-growth ratio of 0.98 and a beta of 0.44.

The Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Friday, May 2nd. The health services provider reported $6.74 EPS for the quarter, topping analysts' consensus estimates of $6.35 by $0.39. The firm had revenue of $65.45 billion for the quarter, compared to analyst estimates of $60.39 billion. The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. The company's revenue was up 14.4% on a year-over-year basis. During the same quarter last year, the company earned $6.47 EPS. On average, equities research analysts expect that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd will be issued a $1.51 dividend. This represents a $6.04 annualized dividend and a yield of 1.93%. The ex-dividend date of this dividend is Tuesday, June 3rd. The Cigna Group's dividend payout ratio is currently 33.44%.

Wall Street Analyst Weigh In

A number of analysts have commented on CI shares. Wall Street Zen upgraded shares of The Cigna Group from a "buy" rating to a "strong-buy" rating in a research note on Tuesday, April 8th. Cantor Fitzgerald lifted their price target on The Cigna Group from $350.00 to $365.00 and gave the stock an "overweight" rating in a report on Thursday, March 20th. Barclays restated an "overweight" rating and issued a $385.00 price objective (up previously from $382.00) on shares of The Cigna Group in a research note on Monday, June 2nd. Piper Sandler lifted their target price on The Cigna Group from $348.00 to $374.00 and gave the stock an "overweight" rating in a research note on Monday, May 5th. Finally, Mizuho increased their price target on The Cigna Group from $360.00 to $384.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Two research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average target price of $380.39.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.